Virta Health · 1 week ago
Proposal Writer, Enterprise Marketing
Maximize your interview chances
DiabetesHealth Care
Insider Connection @Virta Health
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Research, coordinate, write, and produce responses to RFPs that clearly and persuasively address the buyer’s needs
Lead the management and prioritization of proposals to ensure on time completion while proactively considering how adapt processes to scale and improve
Own the RFP library and develop clear, concise, and differentiated client-facing messaging and positioning
Collaborate with sales, marketing, and senior leaders across Clinical and Product to craft effective messages as products and market needs evolve
Partner with internal teams to measure the impact of proposals on Virta’s sales bookings and revenue
Support Product Marketing initiatives such as developing sales content, conducting market research, or enabling commercial teams on new positioning and metrics.
Immerse yourself in Virta’s products, services and go-to-market strategy
Get to know the commercial team and internal SMEs partners
Take ownership of Virta’s RFP and RFI process including proposal intake, prioritization, deadline management, and RFP library
Start supporting proposal deals in partnership with Sales Directors
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
4-6 years of experience in enterprise content creation, proposal writing, or a related role
Strong attention to detail
Strong interpersonal skills
Strong written and verbal communication skills
Ability to work on tight deadlines
Ability to prioritize and handle multiple projects in a fast-paced, deadline driven environment
Preferred
Healthcare experience preferred but not required
Company
Virta Health
Virta delivers a clinically-proven treatment to reverse type 2 diabetes and other chronic metabolic diseases.
Funding
Current Stage
Late StageTotal Funding
$373MKey Investors
Tiger Global ManagementSequoia Capital Global EquitiesCaffeinated Capital
2021-04-19Series E· $133M
2020-12-02Series D· $65M
2020-01-10Series C· $93M
Recent News
2024-05-05
Company data provided by crunchbase